Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

被引:56
作者
Beaton, Melanie D. [1 ]
机构
[1] Univ Western Ontario, Dept Med, Div Gastroenterol, London, ON, Canada
关键词
Fibrosis; Hepatic steatosis; Metabolic syndrome; Treatment; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; VITAMIN-E; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BARIATRIC SURGERY; IRON DEPLETION; METFORMIN;
D O I
10.1155/2012/725468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
MD Beaton. current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. can J gastroenterol 2012;26(6):353-358. Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 76 条
[1]
Increased Fructose Consumption Is Associated with Fibrosis Severity in Patients with Nonalcoholic Fatty Liver Disease [J].
Abdelmalek, Manal F. ;
Suzuki, Ayako ;
Guy, Cynthia ;
Unalp-Arida, Aynur ;
Colvin, Ryan ;
Johnson, Richard J. ;
Diehl, Anna Mae .
HEPATOLOGY, 2010, 51 (06) :1961-1971
[2]
Betaine for Nonalcoholic Fatty Liver Disease: Results of a Randomized Placebo-Controlled Trial [J].
Abdelmalek, Manal F. ;
Sanderson, Schuyler O. ;
Angulo, Paul ;
Soldevila-Pico, Consuelo ;
Liu, Chen ;
Peter, Joy ;
Keach, Jill ;
Cave, Matt ;
Chen, Theresa ;
McClain, Craig J. ;
Lindor, Keith D. .
HEPATOLOGY, 2009, 50 (06) :1818-1826
[3]
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis [J].
Adams, LA ;
Zein, CO ;
Angulo, P ;
Lindor, KD .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2365-2368
[4]
Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study [J].
Adams, Leon A. ;
Harmsen, Scott ;
St Sauver, Jennifer L. ;
Charatcharoenwitthaya, Phunchai ;
Enders, Felicity B. ;
Therneau, Terry ;
Angulo, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) :1567-1573
[5]
Nonalcoholic fatty liver disease [J].
Alfie, ME ;
Treem, WR .
PEDIATRIC ANNALS, 2006, 35 (04) :290-+
[6]
Anderson GJ, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P145
[7]
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis [J].
Angelico, F. ;
Burattin, M. ;
Alessandri, C. ;
Del Ben, M. ;
Lirussi, F. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)
[8]
[Anonymous], PEDIAT ANN
[9]
[Anonymous], 2004, IMPR HLTH CAN
[10]
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study [J].
Athyros, Vasilios G. ;
Mikhailidis, Dimitri P. ;
Didangelos, Triandafillos P. ;
Giouleme, Olga I. ;
Liberopoulos, Evangelos N. ;
Karagiannis, Asterios ;
Kakafika, Anna I. ;
Tziomalos, Konstantinos ;
Burroughs, Andrew K. ;
Elisaf, Moses S. .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) :873-883